|
VC, cleantech, and biotech players populated the New England deal news this week.
—Cambridge, MA-based coal-to-natural-gas company GreatPoint Energy formed a $1.25 billion partnership with China Wanxiang Holdings, according to a report in Dow Jones VentureWire. The deal also included $420... Read more »
Watertown, MA-based Enanta Pharmaceuticals just took a step ahead in the hepatitis C drug development derby.
Enanta said today it has secured an exclusive deal with Novartis to co-develop an experimental hepatitis C drug, dubbed EDP-239, that’s designed to work by blocking a protein called... Read more »
[Updated and corrected, 10:15 am PT] Steve Jobs used to love being on stage, getting the audience in the palm of his hand. Famously, he’d say, “Oh, and one more thing,” to build suspense right before delivering some stunning... Read more »
The roller coaster known as Cell Therapeutics is back on the ascent today.
The Seattle-based biotech company (NASDAQ: CTIC) said its experimental lymphoma drug pixantrone (Pixuvri) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human... Read more »
Clinical trial advances, new financing, and personnel moves made up the New England life sciences news this week.
—Biogen Idec (NASDAQ: [[ticker:BIIB]) scooped up Cambridge, MA-based drugmaker Stromedix for $75 million upfront and potentially $487.5 million more to come in milestone payments... Read more »
Waltham, MA-based MicroCHIPS announced today that its lead product—an implantable, wireless, chip-based device that delivers a drug to treat the bone disease osteoporosis—performed well in its first human trial. The study, published in the online edition of the journal Science Translational Medicine,... Read more »
Westlake Center is the place in Seattle to shop, people watch, or protest. It’s not exactly ground zero for hotshot medical device startups. But to Amp Orthopedics, the town’s downtown retail core was as good a place as any to pursue its... Read more »
President and CEO, Onyx Pharmaceuticals
Former CEO, Calistoga Pharmaceuticals
Chairman, Entrepreneurship Ventures, Inc.
Founding Director, Massachusetts Technology Transfer Center
Partner, Mohr, Davidow Ventures
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
